Henderson Jane
CIK 0001422304
Chief Financial OfficerDirector
Filings
30
Latest May 4, 2026
Issuers covered
5
Showing
30 of 30
Page 1
Track record
23 of 26 open-market trades scored (88% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 23 | 39% | -5.2% | -9.0% | +20.6% | -21.6% |
| 90 days | 16 | 31% | -8.7% | -11.3% | +12.8% | -27.3% |
| 180 days | 5 | 20% | -10.7% | -16.8% | +29.9% | -34.4% |
| 365 days | 1 | 100% | +23.6% | +23.6% | +23.6% | +23.6% |
Issuers
Companies where Henderson Jane has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | 15 | May 4, 2026 |
| AKRO | Akero Therapeutics, Inc. | 7 | Dec 9, 2025 |
| ISEE | Iveric Bio, Inc. | 4 | Jul 13, 2023 |
| CRGX | Cargo Therapeutics, Inc. | 3 | Aug 19, 2025 |
| IVVD | Invivyd, Inc. | 1 | Feb 1, 2022 |
All filings
30 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|